Long Ideas - Raptor Pharmaceutical (NASDAQ:RPTP) is developing treatments for rare diseases and has a compelling pipeline positioned to take advantage of unmet medical needs. The company has … Continue Reading
Read nowLong Ideas - Shares of ViroPharma (NASDAQ:VPHM) have been pressured in 2012 (falling over 17% as of December 26), as generic competition for one of its drugs has … Continue Reading
Read nowLong Ideas - Orexigen Therapeutics (OREX) will be the last of three leading weight-loss drug developers to enter the large potential market for new obesity treatments, and biotech … Continue Reading
Read nowLong Ideas - Finally, some Vertex (NASDAQ:VRTX) news unrelated to Hepatitis C. Health Canada, the Canadian medicinal regulatory body, approved Vertex’s Kalydeco (ivacaftor) on Monday for the treatment … Continue Reading
Read nowLong Ideas - Investors who choose to invest in speculative stocks often choose the biotechnology sector as their sector of choice. It’s easy to understand why; biotechnology companies … Continue Reading
Read nowLong Ideas - In the next several weeks, Keryx Biopharmaceuticals (KERX) will release results from 4 key Phase III trials for its primary drug candidate, Zerenex. The drug … Continue Reading
Read nowMost Popular - We offered some insight this week into how social media can drive the markets. Jason Napodano noted recent performance from SRPT, and discussed what patient-investor … Continue Reading
Read now